Weekly Recap | Twist Bioscience +3.19%, consensus target below spotWeekly Review·11 hours agoTWST+0.33%
Weekly Recap | Kodiak Sciences +191.96%, Zenkuda hits phase 3 goalWeekly Review·13 hours agoKOD-4.07%
Weekly Recap | BioNTech SE this week, CEO trims shares repeatedlyWeekly Review·13 hours agoBNTX+0.05%
Weekly Recap | SPDR S&P Biotech -0.39%, busy week of biotech headlinesWeekly Review·15 hours agoXBI-0.05%
The Nasdaq Biotechnology Index rose by 1.11%. Among the constituent stocks, Prime Medicine increased by 10.46%, while Amylyx Pharmaceuticals, Lexicon Pharma, Kyverna Therapeutics, and Foghorn rose by 9.51% to 8.89%. In contrast, Amarin fell by 5.08%, Alpha Teknova dropped by 6.65%, and Q32 Bio saw a significant decline of 23.68%Wallstreetcn·Jul 14, 2025 at 09:12 PMLXRX0.00%AMLX-1.03%
